NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 332 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,090 | -25.3% | 680 | -17.9% | 0.00% | 0.0% |
| Q2 2023 | $40,290 | -65.1% | 828 | -60.2% | 0.00% | -50.0% |
| Q1 2023 | $115,371 | +24.5% | 2,078 | -9.9% | 0.00% | 0.0% |
| Q4 2022 | $92,672 | -87.3% | 2,307 | -86.1% | 0.00% | -86.7% |
| Q3 2022 | $727,000 | +20.4% | 16,592 | -2.6% | 0.02% | +36.4% |
| Q2 2022 | $604,000 | -18.6% | 17,035 | -6.6% | 0.01% | 0.0% |
| Q1 2022 | $742,000 | -60.2% | 18,247 | -8.6% | 0.01% | -59.3% |
| Q4 2021 | $1,864,000 | -54.1% | 19,962 | -45.3% | 0.03% | -56.5% |
| Q3 2021 | $4,065,000 | -0.8% | 36,473 | +1.1% | 0.06% | +3.3% |
| Q2 2021 | $4,096,000 | +21.4% | 36,080 | +8.6% | 0.06% | +15.4% |
| Q1 2021 | $3,373,000 | +39.0% | 33,217 | +36.2% | 0.05% | +30.0% |
| Q4 2020 | $2,426,000 | +190.2% | 24,382 | +110.6% | 0.04% | +166.7% |
| Q3 2020 | $836,000 | – | 11,575 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |